$57.860
-0.029 (-0.05%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ELVN Prediction & Forecast by Similar Chart Analysis
Alphio's ELVN stock price prediction model matches the current Enliven Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $57.18 (-1.18%). The 1-week path is $58.08 (+0.38%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Enliven Therapeutics Inc Stock?
Enliven Therapeutics is currently trading at $57.86, which is below the average analyst price target of $75, indicating potential upside. However, the RSI is at 31.61, suggesting the stock is oversold, and the company has reported consistent net losses, with Q2 EPS at -0.49, missing expectations. The main risk is the ongoing negative earnings trend, with a projected net income loss of approximately $32 million for Q2 2026.
ELVN stock price ended at $57.86 on Tuesday, after losing -0.05%
Enliven Therapeutics Inc (ELVN) last closed at $57.86, losing -0.05%. These facts feed the 1-day and 1-week ELVN price prediction above.
Forecast Drivers
Enliven Therapeutics Inc (ELVN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ELVN, ranked by similarity.
Seasonality analysis for ELVN
Historically the probability of a positive September return for ELVN is 51.16%. April offers the highest probability of a positive month at 67.19%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ELVN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $16.82 | $21.17 | $22.08 | -63.42% |
| Oct 2026 | $16.08 | $20.22 | $24.88 | -65.05% |
| Nov 2026 | $27.09 | $27.36 | $27.66 | -52.71% |
| Dec 2026 | $17.27 | $21.26 | $25.90 | -63.25% |
In 2026, Enliven Therapeutics Inc (ELVN) is projected to range from $16.08 to $27.66.
Enliven Therapeutics Inc 2026 monthly forecast
In Sep 2026, Enliven Therapeutics Inc is projected to average $21.17, with a low of $16.82 and high of $22.08.
In Oct 2026, Enliven Therapeutics Inc is projected to average $20.22, with a low of $16.08 and high of $24.88.
In Nov 2026, Enliven Therapeutics Inc is projected to average $27.36, with a low of $27.09 and high of $27.66.
In Dec 2026, Enliven Therapeutics Inc is projected to average $21.26, with a low of $17.27 and high of $25.90.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.